Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
about
Current and emerging azole antifungal agentsBlastomycosis in Ontario, 1994-2003Histoplasmosis: a clinical and laboratory updateSuccessful treatment of osseous blastomycosis without pulmonary or disseminated disease and review of the literature.Outbreak of histoplasmosis among employees in a paper factory--Michigan, 1993In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeastsHistory of medical mycology in the united states.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerSusceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.Clinical and laboratory update on blastomycosis.Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.Primary cutaneous blastomycosis as a cause of acute respiratory distress syndrom: case report and literature review.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theIntravenous itraconazole.Antifungal clinical trials and guidelines: what we know and do not knowClinical hepatotoxicity associated with antifungal agents.[Histoplasmosis].Management of histoplasmosis.Histoplasmosis Masquerading as a Rheumatoid Nodule in an Immunocompromised Host: A Case Report.Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis.Effect of fluconazole on viability of Candida albicans over extended periods of timeBlastomycosis and Pregnancy: An Unusual Postpartum Disease CourseBlastomycosis acquired by three children in Toronto.Use of a colorimetric system for yeast susceptibility testing.Fluconazole (Diflucan).Chronic disseminated cutaneous blastomycosis in an 11-year old, with a brief review of the literature.Clinical pharmacology of antifungal agents in pediatric patients.Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.Current options in antifungal pharmacotherapy.Treatment of endemic mycoses.Management of fungal lung disease in the immunocompromised.Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections.Endemic fungal infections in inflammatory bowel disease associated with anti-TNF antibody therapy.Invasive candidiasis: update on current pharmacotherapy options and future perspectives.Tropical respiratory medicine. 3. Histoplasmosis and pulmonary involvement in the tropics.Effect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice.Endemic mycoses in AIDS: a clinical review.Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards.Growing PET positive nodule in a patient with histoplasmosis: case report.It's on the tip of my tongue.
P2860
Q24550733-A8C2F8B0-1038-4F1F-8419-DD7681755C09Q24605411-40EC85F6-E7EB-469C-B204-F250A5A758A9Q24675642-22185D9A-3F37-4F96-96F6-9354D52DAB58Q26998962-735CB2D2-DDA8-480D-8A27-2BEBDD86B4BFQ28285668-FA001EF7-A677-4DB5-AEE0-2069375B713FQ28379385-4E9A68F6-C06D-494C-8FE9-5A7531E2EAFDQ30452877-427B1B51-631D-473E-88B3-FC70C6236A17Q33650105-26035ABE-59BA-4233-9E9A-AB0616580969Q33693076-ADB2CF18-50A5-44C7-ADEF-5738D730EDA1Q33825592-0B7E2A50-5E0C-4E09-A994-CCDE4C8B4BB0Q33976048-109B9968-2DA6-415D-96CD-E4B423027908Q34074183-F2A6FE6F-C9D1-402D-A65B-9DBB1323DFCDQ34212799-86D07589-E15D-4C85-8A96-3531C027CC79Q34284268-E28FDDA1-5AFA-4A07-BB49-881062D8FF53Q34400255-797BF209-B0CB-470F-B344-97B429153689Q34546811-66E0F112-6C3A-40D3-A7DD-A5ACF6598076Q34607789-A43E1D4F-D9EC-4019-94B5-CCDD286B05A1Q34768480-AD1BE923-0A30-4E75-B95D-D4C65BAAB51AQ34910933-27540348-6E6C-489E-B0AC-172B51214C5AQ35112762-D289663C-3DDD-4444-B09E-605613DD7777Q35129406-1BAE7516-8B71-4864-AFD6-7BA3E7D334DEQ35773206-4B27B058-5588-493B-858D-48506F1CFDE2Q36170554-5AC632DC-A5FD-488F-9854-A9B6E2F2E15BQ36520746-2230D510-46EC-4B0B-BDCA-B35C74CB9E49Q36624924-ED21E096-EACB-45B0-BECE-9C87A5809EABQ36677592-A59B2BA7-7972-4470-9D00-A3DECFAB82EAQ36968140-C7E50D05-5BF9-49CE-BA34-513AAF0BF11AQ37096795-1249BEE6-A4E3-47C7-B015-C12DCC9212E1Q37151326-292572A7-05E2-4C3E-B0C7-6A456F41190EQ37729998-58910C1C-697D-43F8-AB5A-6162D6A79DF0Q37909774-6CA42611-7282-42B4-840F-72F614000F60Q38103889-A740D4CE-E9F1-4E63-9FF2-7AEBA9673213Q38108468-C97AE56C-5B18-42AD-8CA9-F35151D99747Q38110850-BF6D891D-59B1-402F-800F-512A0ED289F4Q39079593-12432E38-D6D0-4BC4-B6FA-F17E389C33EFQ39658166-8B20BBAC-0FFC-45DC-9489-B124AD987DD3Q39820555-94BE7254-6099-4640-8455-32915896BBD6Q40285846-F486BC37-4DAE-406D-BD54-4C919440ACF5Q40291302-EAA884C2-0A44-490B-8E5F-A4C827CE6A5FQ40479467-E0CFBED2-BEC0-4A8F-BE56-D43DB3D1B754
P2860
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
@en
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
@nl
type
label
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
@en
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
@nl
prefLabel
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
@en
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
@nl
P2093
P1476
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
@en
P2093
C A Kauffman
C Bowles-Patton
D A Stevens
R B George
R W Bradsher
S W Chapman
W E Dismukes
W M Girard
P304
P356
10.1016/0002-9343(92)90575-V
P407
P577
1992-11-01T00:00:00Z